98%
921
2 minutes
20
Purpose Of Review: An HIV cure that eliminates the viral reservoir or provides viral control without antiretroviral therapy (ART) is an urgent need in children as they face unique challenges, including lifelong ART adherence and the deleterious effects of chronic immune activation. This review highlights the importance of nonhuman primate (NHP) models in developing an HIV cure for children as these models recapitulate the viral pathogenesis and persistence.
Recent Findings: Several cure approaches have been explored in infant NHPs, although knowledge gaps remain. Broadly neutralizing antibodies (bNAbs) show promise for controlling viremia and delaying viral rebound after ART interruption but face administration challenges. Adeno-associated virus (AAV) vectors hold the potential for sustained bNAb expression. Therapeutic vaccination induces immune responses against simian retroviruses but has yet to impact the viral reservoir. Combining immunotherapies with latency reversal agents (LRAs) that enhance viral antigen expression should be explored. Current and future cure approaches will require adaptation for the pediatric immune system and unique features of virus persistence, for which NHP models are fundamental to assess their efficacy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10859349 | PMC |
http://dx.doi.org/10.1007/s11904-023-00686-6 | DOI Listing |
Microb Biotechnol
September 2025
KU Leuven, Department of Biosystems, Laboratory of Gene Technology, Leuven, Belgium.
In this millennium, Marburgvirus (MARV) outbreaks with very high mortality but still small case numbers (< 400) were observed with increasing frequency in Africa. Ecologists identified Egyptian Rousettus bats (ERB) as viral reservoir species causing occasional zoonotic spillover events, mostly in humans intruding into their cave habitats as miners or tourists. So far only short human-to-human transmission chains have been documented.
View Article and Find Full Text PDFMol Ther
September 2025
Sanofi Genomic Medicine Unit, Waltham, USA, 02451. Electronic address:
Tau reduction is a promising therapeutic approach with the potential to slow the progression of Alzheimer's disease. Here, we propose adeno-associated viral (AAV) delivery of an artificial miRNA (amiRNA) targeting the microtubule-associated protein tau (MAPT) mRNA for sustained tau reduction with a single therapeutic injection. Out of 22 initial designs, we identified potent, accurately processed, and highly specific amiRNA candidates.
View Article and Find Full Text PDFThe placenta is a complex organ with multiple immune and non-immune cell types that promote fetal tolerance and facilitate the transfer of nutrients and oxygen. The nonhuman primate (NHP) is a key experimental model for studying human pregnancy complications, in part due to similarities in placental structure, which makes it essential to understand how single-cell populations compare across the human and NHP maternal-fetal interface. We constructed a single-cell RNA-Seq (scRNA-Seq) atlas of the placenta from the pigtail macaque ( ) in the third trimester, comprising three different tissues at the maternal-fetal interface: the chorionic villi (placental disc), chorioamniotic membranes, and the maternal decidua.
View Article and Find Full Text PDFMagn Reson Med
September 2025
Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA.
Purpose: To improve single-shot spiral MR-Acoustic Radiation Force Imaging (MR-ARFI)'s robustness to dynamic phase errors and evaluate it in non-human primates (NHPs) with a low-f-number transducer.
Methods: A single-shot spiral MR-ARFI pulse sequence with 2 mm in-plane resolution and alternating displacement phase contrast was implemented to visualize the focus generated by a 128-element ultrasound transducer in the NHP brain. A model-based displacement map calculation was implemented to remove dynamic phase errors.
Neurobiol Dis
August 2025
Department of Neurology, University of Minnesota, Minneapolis, MN, United States. Electronic address:
Mounting evidence suggests that elevated beta oscillatory activity in the basal ganglia thalamocortical (BGTC) network is associated with the cardinal motor signs in people with Parkinson's disease (PD). The evolution of abnormal beta oscillatory activity across the BGTC network as motor signs emerge, however, is not well understood. The goal of this study was to investigate whether beta oscillatory activity in the BGTC network changes prior to and how it evolves during the emergence of mild parkinsonian motor signs.
View Article and Find Full Text PDF